Musaffa Logo
Alphamab Oncology ALMOF
$1.02

Last Updated: Aug 18, 12:00 AM·OOTC

Pricing for US stocks is delayed by 24 hours

ALMOF Shariah Compliance

Screening Methodology: AAOIFI

As of August 2026, Alphamab Oncology is classified as not halal.

NOT HALAL

Report Source: undefined Quarter Report

Alphamab Oncology

Alphamab Oncology. Stock Analysis ALMOF

United States Health Care Small Cap

Alphamab Oncology (ALMOF) Chart

Financial Metrics & Statements of Alphamab Oncology (ALMOF)

FAQ's for Alphamab Oncology (ALMOF)

  • As of August 2026, Alphamab Oncology ALMOF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Alphamab Oncology using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Alphamab Oncology if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Alphamab Oncology by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Alphamab Oncology may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Alphamab Oncology on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.